BIOVERATIV INC. (BIVV) financial statements (2020 and earlier)

Company profile

Business Address 225 2ND AVENUE
WALTHAM, MA 02451
State of Incorp. DE
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2017
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments437
Cash and cash equivalents437
Receivables189
Inventory, net of allowances, customer advances and progress billings41
Inventory41
Other current assets72
Other undisclosed current assets40
Total current assets:778
Noncurrent Assets
Property, plant and equipment24
Intangible assets, net (including goodwill)807
Goodwill171
Intangible assets, net (excluding goodwill)636
Other noncurrent assets8
Deferred tax assets, net1
Total noncurrent assets:840
TOTAL ASSETS:1,618
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities153
Accounts payable26
Accrued liabilities65
Employee-related liabilities52
Taxes payable9
Due to related parties91
Business combination, contingent consideration, liability49
Other undisclosed current liabilities98
Total current liabilities:390
Noncurrent Liabilities
Liabilities, other than long-term debt331
Deferred tax liabilities, net89
Other liabilities93
Business combination, contingent consideration, liability149
Total noncurrent liabilities:331
Total liabilities:721
Stockholders' equity
Stockholders' equity attributable to parent898
Common stock0
Additional paid in capital565
Retained earnings332
Total stockholders' equity:898
TOTAL LIABILITIES AND EQUITY:1,618

Income statement (P&L) ($ in millions)

12/31/2017
Revenues
(Revenue, Net)
1,169
Cost of revenue
(Cost of Goods and Services Sold)
(288)
Other undisclosed gross profit9
Gross profit:889
Operating expenses(442)
Operating income:447
Nonoperating income5
Income from continuing operations before income taxes:452
Income tax expense(96)
Net income available to common stockholders, diluted:356

Comprehensive Income ($ in millions)

12/31/2017
Net income:356
Other comprehensive loss(2)
Comprehensive income, net of tax, attributable to parent:354

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: